Status:
COMPLETED
High Flow Oxygen Therapy Versus Conventional Oxygen Therapy in Cardiac Surgery Patients
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
High flow oxygen therapy has been applied after extubation in cardiac surgery patients with uncertain efficacy. The current authors plan to conduct a prospective, randomized, controlled study of nasal...
Detailed Description
Over the past decade, nasal high flow (NHF) has been introduced for oxygen therapy in adults. Its indications have been expanded, especially in cases of acute hypoxemic respiratory failure. The devic...
Eligibility Criteria
Inclusion
- Cardiac ICU adult patients
- \>18 years
- After elective or urgent cardiac surgery
- Successful Spontaneous Breathing Trial (SBT) with T-piece and FiO2=60%.
- pO2/ FiO2 \<200
- Hemodynamically stable (160\>SAP\>90mmHg)
Exclusion
- Obstructive Sleep Apnea Syndrome supported by CPAP
- COPD, officially diagnosed, respiratory failure with serum blood ph \<7,35.
- Patients with tracheostomy,
- DNR status,
- Glasgow Coma Scale score \< 13,
- Insufficient knowledge of Greek Language
- Visual or hearing impairment.
Key Trial Info
Start Date :
October 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2019
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT03282552
Start Date
October 30 2017
End Date
October 17 2019
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelismos General Hospital of Athens
Athens, Attica, Greece, 10676